Point of care ultrasound is moving from emergency rooms into aesthetic clinics, where it is being used to map vessels, confirm injection planes and troubleshoot complications in real time. High frequency probes can visualise superficial soft tissue with impressive detail, so practitioners can plan, inject and document with far greater confidence than with palpation alone. Early studies and expert guidance suggest that ultrasound guidance lowers risk and improves placement accuracy, particularly in high stakes areas like the midface and temples.

Clinics offering botulinum toxin are being told to audit their cold-chain now or risk non-compliance when England’s new licensing regime lands. The Cosmetic Practice Standards Authority (CPSA) requires botulinum toxin to be stored in a lockable, purpose-built medicines refrigerator that maintains a stable +2 °C to +8 °C with routine temperature auditing and records.

Breast augmentation is being rethought. Patients who once asked for obvious volume now arrive with screenshots of neat, high-sitting results that read as athletic and proportionate. In clinic language this is the ballerina breast look. It signals a preference for control over conspicuity, and it is changing the pre-op conversation across the UK and beyond.

The UK government has unveiled new plans to regulate the aesthetics industry, targeting unsafe practices that have left patients injured, scarred or requiring urgent NHS care. Under the proposed measures, only qualified healthcare professionals will be allowed to perform the most high-risk procedures, including non-surgical Brazilian butt lifts. These treatments must take place in Care Quality Commission registered clinics.

A new report from Swiss aesthetics brand Teoxane reveals a sharp rise in interest among UK men seeking non-surgical cosmetic procedures, with an estimated 5.2 million now considering dermal filler treatment.

Khloé Kardashian recently took to social media to clarify what cosmetic treatments and procedures she has had, putting to rest years of speculation. For the beauty industry, this moment of honesty offers a rare opportunity to explore the practical and clinical value of her choices. Her routine highlights the evolution of non-surgical aesthetics and shows how celebrities are embracing gradual, strategic enhancements rather than dramatic overhauls.

Despite the growing number of injectable products on the market, only seven botulinum toxin type A formulations are currently licensed by The Medicines and Healthcare Products Regulatory Agency (MHRA) for aesthetic use in the UK. Each has undergone rigorous evaluation for safety, quality and efficacy. For practitioners, the real point of interest lies in how these products differ in formulation, clinical behaviour and treatment outcomes.

Getting anti-wrinkle injections in your 20s, I have learnt, is a controversial thing to do, and I have to admit, it's not something I thought I would be doing at the age of 27. With the rise of popularity in aesthetic treatments (and alongside this, of my insecurities) I knew I would be getting anti-wrinkle injections sooner rather than later, but I had envisioned waiting until I hit 30. But what would really change when I entered into my third decade of life? After my consultation with Dr Ash Soni, my mind was settled. There was no point waiting when the frown lines at rest were already appearing, and so I began my Botox journey.